• Josh Ginsburg
    $CYNA - Took a position here this morning. Nice 5052B play for PD!
    12/27/13
    Reply (8)
    • russleehowe: Me too. 2,000 shares at 0.44. Not exactly a big $ risk, but an interesting little possibility.
      12/27/13
    • GVT: when is the data release expected?
      12/27/13
    • Josh Ginsburg: Glad to hear Russ and good luck! GVT, the data is expected in January, but projected catalysts are often missed in biotech stocks so say Q1.
      12/27/13
    • GVT: What is the price target?
      12/27/13
    • petethepanzer: another company is working on a levodopa inhaler which would make sublingual apomorphine useless imo
      12/27/13
    • Josh Ginsburg: Levodopa has been used to treat PD patients since the 1960's. The inhaler is merely aimed to be faster acting. It doesn't mean much to me.
      12/28/13
    • petethepanzer: i can see them both being useful its hard to say...after january should be 40m cap
      12/29/13
    • petethepanzer: jason napos target is a bit high imo
      12/30/13